Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 809 results for "bayer ag"

FDA Approves Bayer's Finacea® (azelaic acid) Foam, 15% for th...

/PRNewswire/ -- Bayer HealthCare today announced that the U.S. Food and Drug Administration (FDA) has approved Finacea (azelaic acid) Foam, 15% for the topical treatment of the inflammatory papules and pustules of mild to moderate rosacea. The ... Bloomberg, 1 day ago

European Stocks Advance for Second Day on Earnings, M&A Boost

European stocks had their biggest two-day gain in two weeks as companies from Bayer AG to PSA Peugeot Citroen reported better-than-estimated earnings and deals activity intensified. Bayer and Peugeot rose more than 3.9 percent. GlaxoSmithKline ...
 Bloomberg3 days ago M&A, Earnings Spur Second Day of Advances in European Equities  La Repubblica3 days ago Europe Index Futures Advance, Indicating Second Day of Rebound  Washington Post3 days ago Earnings, M&A Spur Second Day of Advances in European Equities  La Repubblica3 days ago
India Infoline

Glenmark Pharma says: Court decision has no material impact on company

Earlier, a US court ruled that Glenmark Pharmaceuticals proposed generic version of Bayer AG's Finacea infringes Bayer's patent. Glenmark in its official statement said that it is not generating any revenues out of the said product. With reference to the news ...
 India Infoline3 days ago BRIEF: US court rejects Glenmark's patent plea, stock down 3% [Mint, New Delhi]  Bloomberg4 days ago Glenmark Pharmaceuticals' Finacea generic infringes Bayer patent - court  Reuters5 days ago US court rejects Glenmark's patent plea; stock falls 4.21%  Livemint.com4 days ago

Bayer CEO: No Plans to Buy Syngenta

National & World Ag News Headlines USAgNet - 07/31/2015 The CEO of German drugmaker Bayer has quashed any talk of acquiring its competitor Syngenta, which is currently being pursued by U.S. firm Monsanto. "I would say that Syngenta is not a ...
 USAgNet1 day ago Bayer CEO Weighs In On Guidance, Listing Of Material Science Business And Syngenta  Benzinga.com3 days ago Bayer's Profits Rise on Healthy Currency Effects  4 Traders3 days ago Bayer Sees Benefits of Currency Effects With 21% Rise in 2Q Profit  4 Traders3 days ago

Polycoat Acquires Crown Polymers, Bayer MaterialScience Launches INSQIN, Global Bioenergies Bio-Isobutene Process to Utilize Sucrose

Hello and welcome to your late week international coatings industry update, brought to you by SpecialChem. The news for this issue was dominated by announcements of fine financial results among industry players. Apparently, the economy overall ...
 Special Chem 4 Coatings Ingredients2 days ago

Bayer Earnings Beat Estimates on Blood Thinner, Consumer Brands

(Bloomberg) -- Bayer AG's second-quarter earnings beat analysts estimates, helped by the blood thinner Xarelto and the addition of Merck & Co.'s consumer-health business. Earnings before interest, taxes, amortization, depreciation and special ...
 Washington Post3 days ago Bayer Earnings Beat Estimates on Xarelto and Plastics Division  La Repubblica3 days ago
Pharmaceutical Business Review

Sprint Bioscience signs licensing agreement with Bayer HealthCare

Sprint Bioscience AB, a Sweden-based drug development company, has entered into a collaboration and licensing agreement with Bayer HealthCare AG, a Germany-based company engaged in the research, development, manufacturing and marketing of healthcare ...
 Individual.com4 days ago Bayer, Sprint Bioscience partner to develop new oncology drug candidates  Pharmaceutical Business Review3 days ago Bayer HealthCare Enters Into Collaboration With Sprint Bioscience On Tumor Metabolism Program  FirstWord Pharma4 days ago BAYER : Not intended for U.S. and UK Media -- Bayer HealthCare Enters Into Collaboration With Sprint Bioscience On Tumor Metabolism Program  4 Traders4 days ago

German stocks - Factors to watch on July 28

Jul 28 The following are some of the factors that may move German stocks on Tuesday: BAYER India's Glenmark Pharmaceuticals' proposed generic version of Bayer AG's Finacea, a gel for treating the common skin condition rosacea, infringes Bayer's ...
 Reuters4 days ago German Stocks Steady Before Fed Decision  Nasdaq3 days ago

Earnings at Bayer, Peugeot Send Europe Stocks Higher for 2nd Day

(Bloomberg) -- Better-than-estimated earnings at companies from Bayer AG to PSA Peugeot Citroen pushed European stocks higher for a second day. Bayer, Peugeot and British American Tobacco Plc rose more than 2.7 percent after reporting earnings ...
 La Repubblica3 days ago

Bayer: MaterialScience Listing May Come Before Mid-2016

Bayer AG's spinoff or initial public offering of its MaterialScience plastics unit may come earlier than mid-2016, says Chief Executive Officer Marijn Dekkers. He spoke with Jonathan Ferro on Bloomberg's "On the Move" as second-quarter earnings beat ...
 Bloomberg3 days ago BAYER : MaterialScience - Covestro premiere at Fakuma  4 Traders1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - bayer ag
Get updated on latest news & your favorite topics right in your inbox!
More     Less